TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression

被引：772
作者：
Yang, Li [1 ]
Pang, Yanli [1 ]
Moses, Harold L. [2 ]
机构：
[1] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20876 USA
[2] Vanderbilt Univ, Sch Med, Dept Canc Biol, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
来源：
TRENDS IN IMMUNOLOGY | 2010年 / 31卷 / 06期
关键词：
GROWTH-FACTOR-BETA; NF-KAPPA-B; T-CELLS; MYELOID CELLS; COLON-CANCER; PROMOTE METASTASIS; LUNG METASTASIS; BREAST-CANCER; IN-VIVO; INFLAMMATION;
D O I：
10.1016/j.it.2010.04.002
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Transforming growth factor beta (TGF-beta) plays an important role in tumor initiation and progression, functioning as both a suppressor and a promoter. The mechanisms underlying this dual role of TGF-beta remain unclear. TGF-beta exerts systemic immune suppression and inhibits host immunosurveillance. Neutralizing TGF-beta enhances CD8+ T-cell- and NK-cell-mediated anti-tumor immune responses. It also increases neutrophil-attracting chemokines resulting in recruitment and activation of neutrophils with an antitumor phenotype. In addition to its systemic effects, TGF-beta regulates infiltration of inflammatory/immune cells and cancer-associated fibroblasts in the tumor miwcroenvironment causing direct changes in tumor cells. Understanding TGF-beta regulation at the interface of tumor and host immunity should provide insights into developing effective TGF-beta antagonists and biomarkers for patient selection and efficacy of TGF-beta antagonist treatment.
引用
收藏
页码：220 / 227
页数：8
相关论文
共 86 条
[71]   Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice [J].
Pangas, Stephanie A. ;
Li, Xiaohui ;
Umans, Lieve ;
Zwijsen, An ;
Huylebroeck, Danny ;
Gutierrez, Carolina ;
Wang, Degang ;
Martin, James F. ;
Jamin, Soazik P. ;
Behringer, Richard R. ;
Robertson, Elizabeth J. ;
Matzuk, Martin M. .
MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (01) :248-257
[72]   Trophic macrophages in development and disease [J].
Pollard, Jeffrey W. .
NATURE REVIEWS IMMUNOLOGY, 2009, 9 (04) :259-270
[73]   The two faces of transforming growth factor β in carcinogenesis [J].
Roberts, AB ;
Wakefield, LM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (15) :8621-8623
[74]   Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression [J].
Shevach, Ethan M. .
IMMUNITY, 2009, 30 (05) :636-645
[75]   Transforming growth factor-β production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance:: Abrogation prevents tumor recurrence [J].
Terabe, M ;
Matsui, S ;
Park, JM ;
Mamura, M ;
Noben-Trauth, N ;
Donaldson, DD ;
Chen, WJ ;
Wahl, SM ;
Ledbetter, S ;
Pratt, B ;
Letterio, JJ ;
Paul, WE ;
Berzofsky, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (11) :1741-1752
[76]   Synergistic Enhancement of CD8+ T Cell-Mediated Tumor Vaccine Efficacy by an Anti-Transforming Growth Factor-β Monoclonal Antibody [J].
Terabe, Masaki ;
Ambrosino, Elena ;
Takaku, Shun ;
O'Konek, Jessica J. ;
Venzon, David ;
Lonnin, Scott ;
McPherson, John M. ;
Berzofsky, Jay A. .
CLINICAL CANCER RESEARCH, 2009, 15 (21) :6560-6569
[77]   TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance [J].
Thomas, DA ;
Massagué, J .
CANCER CELL, 2005, 8 (05) :369-380
[78]   The dual adverse effects of TGF-β secretion on tumor progression [J].
Trapani, JA .
CANCER CELL, 2005, 8 (05) :349-350
[79]   TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells [J].
Veldhoen, M ;
Hocking, RJ ;
Atkins, CJ ;
Locksley, RM ;
Stockinger, B .
IMMUNITY, 2006, 24 (02) :179-189
[80]   TGF-β:: a mobile purveyor of immune privilege [J].
Wahl, Sharon M. ;
Wen, Jie ;
Moutsopoulos, Niki .
IMMUNOLOGICAL REVIEWS, 2006, 213 :213-227
123456789